These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 2309160)

  • 21. D1 receptor activation enhances sciatic nerve stimulation-induced inhibition of nigrostriatal dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1989; 3(4):339-45. PubMed ID: 2525823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multisecond oscillations in firing rate in the globus pallidus: synergistic modulation by D1 and D2 dopamine receptors.
    Ruskin DN; Bergstrom DA; Walters JR
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1493-501. PubMed ID: 10454529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
    Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions.
    Mehta A; Menalled L; Chesselet MF
    Neuroscience; 2005; 131(3):769-78. PubMed ID: 15730880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats.
    Jiang HK; Wang JY
    Chin J Physiol; 1991; 34(4):413-25. PubMed ID: 1687937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellularly recorded response of rat striatal neurons in vitro to fenoldopam and SKF 38393 following lesions of midbrain dopamine cells.
    Twery MJ; Thompson LA; Walters JR
    Synapse; 1994 Sep; 18(1):67-78. PubMed ID: 7825125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic mapping of the synergism between MK-801 and SKF 38393 in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Pontieri FE; Morelli M; Orzi F; Terenzi R; Di Chiara G
    Synapse; 1992 Dec; 12(4):255-60. PubMed ID: 1465740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist.
    Morelli M; Pontieri FE; Linfante I; Orzi F; Di Chiara G
    Synapse; 1993 Mar; 13(3):264-9. PubMed ID: 8098880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L; Pitts DK
    J Pharmacol Exp Ther; 1995 Jan; 272(1):164-76. PubMed ID: 7815330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study.
    Carlson JH; Bergstrom DA; Walters JR
    Brain Res; 1987 Jan; 400(2):205-18. PubMed ID: 2880637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
    Kelland MD; Freeman AS; LeWitt PA; Chiodo LA
    J Pharmacol Exp Ther; 1990 Oct; 255(1):276-84. PubMed ID: 1976800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M; Danek L; Smiałowski A
    Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
    Marshall JF; Cole BN; LaHoste GJ
    Brain Res; 1993 Dec; 632(1-2):308-13. PubMed ID: 7908600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT; Wachtel SR; Galloway MP; White FJ
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions.
    Chen MT; Morales M; Woodward DJ; Hoffer BJ; Janak PH
    Exp Neurol; 2001 Sep; 171(1):72-83. PubMed ID: 11520122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey.
    Filion M
    Brain Res; 1979 Dec; 178(2-3):425-41. PubMed ID: 116713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK; McGinty JF; Hong JS
    Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.